Skip to Content

RDY 150 (Capecitabine 150 mg)

Pill with imprint RDY 150 is Peach, Capsule-shape and has been identified as Capecitabine 150 mg. It is supplied by Dr. Reddy's Laboratories, Inc..

Capecitabine is used in the treatment of colorectal cancer; breast cancer, metastatic; breast cancer; anal cancer and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Capecitabine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RDY 150

Capecitabine

Imprint
RDY 150
Strength
150 mg
Color
Peach
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antimetabolites
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Dr. Reddy's Laboratories, Inc.
National Drug Code (NDC)
55111-0496

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.